Fibrin(ogen) in human disease: both friend and foe
Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 days. With fibrin, produced by thrombin-mediated cleavage, fibrinogen plays important roles in many physiological p...
Gespeichert in:
| Veröffentlicht in: | Haematologica (Roma) Jg. 105; H. 2; S. 284 - 296 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Italy
Ferrata Storti Foundation
01.02.2020
|
| Schlagworte: | |
| ISSN: | 0390-6078, 1592-8721, 1592-8721 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 days. With fibrin, produced by thrombin-mediated cleavage, fibrinogen plays important roles in many physiological processes. Indeed, the formation of a stable blood clot, containing polymerized and cross-linked fibrin, is crucial to prevent blood loss and drive wound healing upon vascular injury. A balance between clotting, notably the conversion of fibrinogen to fibrin, and fibrinolysis, the proteolytic degradation of the fibrin mesh, is essential. Disruption of this equilibrium can cause disease in distinct manners. While some pathological conditions are the consequence of altered levels of fibrinogen, others are related to structural properties of the molecule. The source of fibrinogen expression and the localization of fibrin(ogen) protein also have clinical implications. Low levels of fibrinogen expression have been detected in extra-hepatic tissues, including carcinomas, potentially contributing to disease. Fibrin(ogen) deposits at aberrant sites including the central nervous system or kidney, can also be pathological. In this review, we discuss disorders in which fibrinogen and fibrin are implicated, highlighting mechanisms that may contribute to disease. |
|---|---|
| AbstractList | Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 days. With fibrin, produced by thrombin-mediated cleavage, fibrinogen plays important roles in many physiological processes. Indeed, the formation of a stable blood clot, containing polymerized and cross-linked fibrin, is crucial to prevent blood loss and drive wound healing upon vascular injury. A balance between clotting, notably the conversion of fibrinogen to fibrin, and fibrinolysis, the proteolytic degradation of the fibrin mesh, is essential. Disruption of this equilibrium can cause disease in distinct manners. While some pathological conditions are the consequence of altered levels of fibrinogen, others are related to structural properties of the molecule. The source of fibrinogen expression and the localization of fibrin(ogen) protein also have clinical implications. Low levels of fibrinogen expression have been detected in extra-hepatic tissues, including carcinomas, potentially contributing to disease. Fibrin(ogen) deposits at aberrant sites including the central nervous system or kidney, can also be pathological. In this review, we discuss disorders in which fibrinogen and fibrin are implicated, highlighting mechanisms that may contribute to disease. Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 days. With fibrin, produced by thrombin-mediated cleavage, fibrinogen plays important roles in many physiological processes. Indeed, the formation of a stable blood clot, containing polymerized and cross-linked fibrin, is crucial to prevent blood loss and drive wound healing upon vascular injury. A balance between clotting, notably the conversion of fibrinogen to fibrin, and fibrinolysis, the proteolytic degradation of the fibrin mesh, is essential. Disruption of this equilibrium can cause disease in distinct manners. While some pathological conditions are the consequence of altered levels of fibrinogen, others are related to structural properties of the molecule. The source of fibrinogen expression and the localization of fibrin(ogen) protein also have clinical implications. Low levels of fibrinogen expression have been detected in extra-hepatic tissues, including carcinomas, potentially contributing to disease. Fibrin(ogen) deposits at aberrant sites including the central nervous system or kidney, can also be pathological. In this review, we discuss disorders in which fibrinogen and fibrin are implicated, highlighting mechanisms that may contribute to disease.Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma at concentrations ranging from 1.5-4 g/L in healthy individuals with a normal half-life of 3-5 days. With fibrin, produced by thrombin-mediated cleavage, fibrinogen plays important roles in many physiological processes. Indeed, the formation of a stable blood clot, containing polymerized and cross-linked fibrin, is crucial to prevent blood loss and drive wound healing upon vascular injury. A balance between clotting, notably the conversion of fibrinogen to fibrin, and fibrinolysis, the proteolytic degradation of the fibrin mesh, is essential. Disruption of this equilibrium can cause disease in distinct manners. While some pathological conditions are the consequence of altered levels of fibrinogen, others are related to structural properties of the molecule. The source of fibrinogen expression and the localization of fibrin(ogen) protein also have clinical implications. Low levels of fibrinogen expression have been detected in extra-hepatic tissues, including carcinomas, potentially contributing to disease. Fibrin(ogen) deposits at aberrant sites including the central nervous system or kidney, can also be pathological. In this review, we discuss disorders in which fibrinogen and fibrin are implicated, highlighting mechanisms that may contribute to disease. |
| Author | Neerman-Arbez, Marguerite Fish, Richard J. Casini, Alessandro Vilar, Rui |
| AuthorAffiliation | 3 iGE3, Institute of Genetics and Genomics in Geneva, Geneva, Switzerland 2 Division of Angiology and Hemostasis, University Hospitals and University of Geneva Faculty of Medicine 1 Department of Genetic Medicine and Development, University of Geneva Faculty of Medicine |
| AuthorAffiliation_xml | – name: 2 Division of Angiology and Hemostasis, University Hospitals and University of Geneva Faculty of Medicine – name: 3 iGE3, Institute of Genetics and Genomics in Geneva, Geneva, Switzerland – name: 1 Department of Genetic Medicine and Development, University of Geneva Faculty of Medicine |
| Author_xml | – sequence: 1 givenname: Rui surname: Vilar fullname: Vilar, Rui – sequence: 2 givenname: Richard J. surname: Fish fullname: Fish, Richard J. – sequence: 3 givenname: Alessandro surname: Casini fullname: Casini, Alessandro – sequence: 4 givenname: Marguerite surname: Neerman-Arbez fullname: Neerman-Arbez, Marguerite |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31949010$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kV9rFDEUxYNU7Lb6DUTmsT7Mmn-TTPogSGlroeCLPoc7mZvdlJmkJrOC396s2xXrgw_hQu45vwP3nJGTmCIS8pbRtRBcftgCzrCkac0pM2sulKHsBVmxzvC215ydkBUVhraK6v6UnJXyQCmnxuhX5FQwI6ucrgi_CUMO8SJtML5vQmy2uxliM4aCUPCyGdKybXwOGMcG6vMJX5OXHqaCb57mOfl2c_316nN7_-X27urTfeuklkurhzpkD30HkjujOoWG8c6hlB0MmhupzdAL5zUOHrnpFAzSjQgMDEqk4pzcHbhjggf7mMMM-adNEOzvj5Q3FvIS3IQWkLrBc007paT3FGoCHQWInoNT6Cvr44H1uBtmHB3GJcP0DPp8E8PWbtIPqynj9VQVcPEEyOn7Dsti51AcThNETLtiuZBMCSGorNJ3f2f9CTkevQouDwKXUykZvXVhgSWkfXSYLKN237A9Nmz3DdtDw9Us_zEf-f-1_QJRM6wz |
| CitedBy_id | crossref_primary_10_3389_fendo_2022_830466 crossref_primary_10_1016_j_jep_2024_119034 crossref_primary_10_1016_j_rpth_2025_102689 crossref_primary_10_3390_cancers13071744 crossref_primary_10_3390_ijms21134616 crossref_primary_10_1002_adhm_202300096 crossref_primary_10_1055_s_0040_1721318 crossref_primary_10_1186_s12903_022_02261_8 crossref_primary_10_1111_jth_15555 crossref_primary_10_1128_iai_00476_23 crossref_primary_10_3390_nano12132283 crossref_primary_10_1007_s10856_024_06800_3 crossref_primary_10_1007_s00580_023_03508_8 crossref_primary_10_3389_fped_2021_682839 crossref_primary_10_1038_s41467_023_40371_1 crossref_primary_10_1038_s41551_024_01250_2 crossref_primary_10_1055_s_0040_1718414 crossref_primary_10_4081_btvb_2023_46 crossref_primary_10_1016_j_jflm_2025_102808 crossref_primary_10_1038_s41598_021_00411_6 crossref_primary_10_3390_antiox10122009 crossref_primary_10_1016_j_intimp_2024_113326 crossref_primary_10_1016_j_sajb_2021_09_001 crossref_primary_10_3389_fcvm_2024_1336269 crossref_primary_10_1182_blood_2020010116 crossref_primary_10_1002_ijc_35479 crossref_primary_10_1016_j_jtemb_2021_126802 crossref_primary_10_3390_nu13020674 crossref_primary_10_3390_ijms26125471 crossref_primary_10_3390_biomimetics9040234 crossref_primary_10_1186_s40959_024_00218_0 crossref_primary_10_1016_j_mehy_2020_110453 crossref_primary_10_1002_rmv_2562 crossref_primary_10_3390_ijms252111457 crossref_primary_10_3389_fimmu_2022_916187 crossref_primary_10_3390_ijms26020721 crossref_primary_10_23922_jarc_2024_112 crossref_primary_10_1039_D2NR00976E crossref_primary_10_1186_s43556_024_00214_x crossref_primary_10_1016_j_talanta_2024_126687 crossref_primary_10_1016_j_blre_2020_100793 crossref_primary_10_3390_ijms241612563 crossref_primary_10_1186_s12957_020_01979_5 crossref_primary_10_1038_s41598_025_00507_3 crossref_primary_10_1016_j_jtha_2023_04_013 crossref_primary_10_1055_s_0043_1775857 crossref_primary_10_1007_s00011_024_01916_2 crossref_primary_10_3390_diseases13080246 crossref_primary_10_3390_jcm11041083 crossref_primary_10_3390_ijms25147914 crossref_primary_10_1002_advs_202508271 crossref_primary_10_1016_j_wneu_2025_124072 crossref_primary_10_7759_cureus_16864 crossref_primary_10_1016_j_jacc_2023_09_814 crossref_primary_10_1007_s44200_025_00072_0 crossref_primary_10_1146_annurev_biophys_111821_072110 crossref_primary_10_2174_1875318302111010048 crossref_primary_10_3390_cells14141052 crossref_primary_10_1007_s11239_022_02690_w crossref_primary_10_1007_s11357_023_00988_y crossref_primary_10_3390_ijms25063435 crossref_primary_10_3389_fnut_2025_1562091 crossref_primary_10_3389_fgene_2020_584460 crossref_primary_10_1007_s13410_025_01503_z crossref_primary_10_2147_COPD_S361929 crossref_primary_10_3390_cells13110991 crossref_primary_10_1016_j_actbio_2022_12_028 crossref_primary_10_1016_j_bbi_2025_106069 crossref_primary_10_1111_hae_14754 crossref_primary_10_1016_j_thromres_2021_07_013 crossref_primary_10_1093_neuonc_noaa183 crossref_primary_10_1038_s41598_022_11638_2 crossref_primary_10_1038_s41598_024_66002_3 crossref_primary_10_2147_NSS_S520758 crossref_primary_10_3390_diseases12120313 crossref_primary_10_1038_s41598_024_52844_4 crossref_primary_10_1016_j_actbio_2021_03_070 crossref_primary_10_3389_fmed_2023_1140185 crossref_primary_10_1016_j_hpb_2022_08_007 crossref_primary_10_3390_ijms21228426 crossref_primary_10_1016_j_jmst_2021_12_076 crossref_primary_10_1088_1748_605X_ac3680 crossref_primary_10_1016_j_bbrc_2020_12_024 crossref_primary_10_1016_j_nbd_2023_106001 crossref_primary_10_1177_17085381251379804 crossref_primary_10_1182_blood_2021014559 crossref_primary_10_3390_ijms23010193 crossref_primary_10_1016_j_jiec_2024_12_079 crossref_primary_10_3390_gels10030203 crossref_primary_10_1016_j_cca_2025_120350 crossref_primary_10_3390_ijerph20032567 crossref_primary_10_1016_j_isci_2024_110048 crossref_primary_10_1111_pcmr_12995 crossref_primary_10_1134_S0021364023604153 crossref_primary_10_1182_blood_2024025319 crossref_primary_10_1007_s10072_021_05363_3 crossref_primary_10_3389_fmed_2023_1193303 crossref_primary_10_1055_a_2511_3314 crossref_primary_10_1089_wound_2020_1183 crossref_primary_10_1016_j_jtha_2022_10_027 crossref_primary_10_5937_mckg58_52508 crossref_primary_10_3390_ijms26010171 crossref_primary_10_3390_ijms22136916 crossref_primary_10_3390_jcm13144258 crossref_primary_10_1007_s12032_022_01874_x crossref_primary_10_1111_cns_70545 crossref_primary_10_1016_j_biomaterials_2021_121205 crossref_primary_10_1038_s41598_025_08215_8 crossref_primary_10_3390_ijms25168929 crossref_primary_10_3390_nano12152661 crossref_primary_10_3390_ijms242316551 crossref_primary_10_1097_MBC_0000000000001362 crossref_primary_10_1126_science_abe0348 crossref_primary_10_3390_bioengineering9080390 crossref_primary_10_3390_ijms22063184 crossref_primary_10_1016_j_colsurfb_2025_114821 crossref_primary_10_1186_s40001_023_01029_2 crossref_primary_10_1007_s12028_023_01865_4 crossref_primary_10_1111_ijlh_14201 crossref_primary_10_1016_j_jtha_2023_01_034 crossref_primary_10_1016_j_thromres_2020_12_009 crossref_primary_10_3389_fimmu_2022_866035 crossref_primary_10_3389_fgene_2023_1119017 crossref_primary_10_1038_s44341_025_00011_9 crossref_primary_10_1186_s40001_025_03101_5 crossref_primary_10_12998_wjcc_v9_i35_10805 crossref_primary_10_1002_bio_4764 crossref_primary_10_3390_diagnostics11112140 crossref_primary_10_1016_j_critrevonc_2025_104625 crossref_primary_10_3390_antiox13121456 crossref_primary_10_3390_antiox14040390 crossref_primary_10_3390_pharmaceutics13070981 crossref_primary_10_1109_TIM_2023_3329196 crossref_primary_10_1016_j_arabjc_2024_105948 crossref_primary_10_1038_s41419_023_06242_9 crossref_primary_10_1039_D5AN00401B crossref_primary_10_1182_blood_2023022596 crossref_primary_10_1016_j_surg_2025_109427 crossref_primary_10_1182_blood_2021015215 crossref_primary_10_1016_j_ijbiomac_2024_135125 crossref_primary_10_3390_ijms23062972 crossref_primary_10_3390_ijms23116340 crossref_primary_10_1038_s41467_025_56513_6 crossref_primary_10_1055_s_0041_1742170 crossref_primary_10_3390_jcm11082084 crossref_primary_10_3390_polym14153150 crossref_primary_10_3389_fimmu_2023_1269960 crossref_primary_10_1016_j_thromres_2024_109134 crossref_primary_10_1038_s41380_021_01197_9 crossref_primary_10_1016_j_bvth_2025_100091 crossref_primary_10_3389_fcvm_2021_715842 crossref_primary_10_3389_fcvm_2022_1009926 crossref_primary_10_1016_j_heliyon_2024_e38831 crossref_primary_10_1155_2022_5824327 crossref_primary_10_1016_j_bioactmat_2025_07_005 crossref_primary_10_1186_s12893_025_02955_0 |
| ContentType | Journal Article |
| Copyright | Copyright© 2020 Ferrata Storti Foundation. Copyright© 2020 Ferrata Storti Foundation 2020 |
| Copyright_xml | – notice: Copyright© 2020 Ferrata Storti Foundation. – notice: Copyright© 2020 Ferrata Storti Foundation 2020 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.3324/haematol.2019.236901 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1592-8721 |
| EndPage | 296 |
| ExternalDocumentID | oai_doaj_org_article_ae0cbf2705664ff0a5ab0d3a382ac6ef PMC7012490 31949010 10_3324_haematol_2019_236901 |
| Genre | Journal Article Review |
| GroupedDBID | --- 29I 2WC 53G 5GY 5RE 5VS AAFWJ AAYXX ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW C1A CITATION CS3 DIK E3Z EBS EJD F5P FRP GROUPED_DOAJ H13 HYE KQ8 OK1 OVT P2P RHI RNS RPM SJN TFS TR2 UDS W8F WOQ WOW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c474t-7b47448a85a42c9656e9125ce445ab729479b83cf7ebfe2956ab4cdea1a9e4e03 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 179 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000510846700020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0390-6078 1592-8721 |
| IngestDate | Fri Oct 03 12:49:28 EDT 2025 Thu Aug 21 14:12:36 EDT 2025 Fri Jul 11 11:12:20 EDT 2025 Mon Jul 21 05:56:11 EDT 2025 Sat Nov 29 06:32:56 EST 2025 Tue Nov 18 21:18:48 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | Copyright© 2020 Ferrata Storti Foundation. https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c474t-7b47448a85a42c9656e9125ce445ab729479b83cf7ebfe2956ab4cdea1a9e4e03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doaj.org/article/ae0cbf2705664ff0a5ab0d3a382ac6ef |
| PMID | 31949010 |
| PQID | 2341633304 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ae0cbf2705664ff0a5ab0d3a382ac6ef pubmedcentral_primary_oai_pubmedcentral_nih_gov_7012490 proquest_miscellaneous_2341633304 pubmed_primary_31949010 crossref_citationtrail_10_3324_haematol_2019_236901 crossref_primary_10_3324_haematol_2019_236901 |
| PublicationCentury | 2000 |
| PublicationDate | 20200201 |
| PublicationDateYYYYMMDD | 2020-02-01 |
| PublicationDate_xml | – month: 2 year: 2020 text: 20200201 day: 1 |
| PublicationDecade | 2020 |
| PublicationPlace | Italy |
| PublicationPlace_xml | – name: Italy |
| PublicationTitle | Haematologica (Roma) |
| PublicationTitleAlternate | Haematologica |
| PublicationYear | 2020 |
| Publisher | Ferrata Storti Foundation |
| Publisher_xml | – name: Ferrata Storti Foundation |
| SSID | ssj0020997 |
| Score | 2.6403217 |
| SecondaryResourceType | review_article |
| Snippet | Fibrinogen is an abundant protein synthesized in the liver, present in human blood plasma at concentrations ranging from 1.5-4 g/L in healthy individuals with... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 284 |
| SubjectTerms | Fibrin Fibrinogen Humans Review Thrombin |
| Title | Fibrin(ogen) in human disease: both friend and foe |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31949010 https://www.proquest.com/docview/2341633304 https://pubmed.ncbi.nlm.nih.gov/PMC7012490 https://doaj.org/article/ae0cbf2705664ff0a5ab0d3a382ac6ef |
| Volume | 105 |
| WOSCitedRecordID | wos000510846700020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1592-8721 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020997 issn: 0390-6078 databaseCode: DOA dateStart: 19940101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Bb9UwDLbGNCEuaGwMysYUJDTBoSwvTZuG20A8cYCJwza9W-WkifYkaNH2hsS_n532Pe2hSbtwqCq1SRPZbmzHzmeAt1G1KjqPuW_JRdGtaXOL0eZ19FWojJc-QQpdfDOnp_VsZn_cKfXFOWEDPPBAuGMM0ruoDCnqSscosUQn2wKLWiF9LvLqS1bP0pkaXS0-D5riB5acI9KCw6G5gqyH40tkMNSeww4T-0EVXJFpTSkl7P77DM5_8ybvKKLpNjwdLUhxMsz8GWyEbgd2Tzoa7ddfcSRSTmfaLN-Bx9_H0PkuqCkn93fvepKY92LeiVSdT4wBmo_CEctEZNTjViBdsQ_P4Xz65ezz13wsmJB7bfQiN45uusa6RK28JVMtWDJgfNCaqEZmtDbW1YWPJrgYFLlG6LRvA07QBh1ksQebXd-FlyCkjT6UrStcZbSvIipJ31GTSP2wLDGDYkmxxo9o4lzU4mdDXgXTuVnSuWE6NwOdM8hXvX4PaBoPtP_EzFi1ZSzs9IAkpBklpHlIQjJ4s2RlQ_8OB0SwC_3NNQ3C5ijv6GTwYmDtaihamjSnrmRg1pi-Npf1N938MuFzG8kVveWr_zH5fXii2MNPeeIHsLm4ugmvYcv_Wcyvrw7hkZnVh0n0bwEVmgk3 |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibrin%28ogen%29+in+human+disease%3A+both+friend+and+foe&rft.jtitle=Haematologica+%28Roma%29&rft.au=Vilar%2C+Rui&rft.au=Fish%2C+Richard+J.&rft.au=Casini%2C+Alessandro&rft.au=Neerman-Arbez%2C+Marguerite&rft.date=2020-02-01&rft.pub=Ferrata+Storti+Foundation&rft.issn=0390-6078&rft.eissn=1592-8721&rft.volume=105&rft.issue=2&rft.spage=284&rft.epage=296&rft_id=info:doi/10.3324%2Fhaematol.2019.236901&rft_id=info%3Apmid%2F31949010&rft.externalDocID=PMC7012490 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0390-6078&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0390-6078&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0390-6078&client=summon |